REFERENCES
- Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: Prevalence, impact on daily life and treatment. Eur J Pain 2006; 10: 287–333
- Eurostat Population Statistics, Available at http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-EH-06–001/EN/KS-EH-06–001-EN.PDF 2006 Edition (accessed 20 November 2008)
- Bell T J, Panchal S J, Miaskowski C, et al. The prevalence, severity and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (PROBE 1). Pain Med 2008, doi: 10.1111/j.1526–4637.2008.00495. Pain Med. 2009 Jan; 10(1):35–42
- Thorpe D M. Management of opioid-induced constipation. Curr Pain Headache Rep 2001; 5: 237–240
- Vondrackova D, Leyendecker P, Meissner W, et al. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. J Pain 2008; 9: 1144–1154
- Meissner W, Leyendecker P, Müller-Lissner S, et al. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain 2008, doi:10.1016/j.ejpain.2008.06.012. 2009 Jan; 13(1):56–64
- Simpson K, Leyendecker P, Hopp M, et al. Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe non-cancer pain. Curr Med Res Opin 2008; 24: 3503–3512
- Riley J, Eisenberg E, Müller-Schwefe G, et al. Oxycodone: a review of its use in the management of pain. Curr Med Res Opin 2008; 24: 175–192
- Nadstawek J, Leyendecker P, Hopp M, et al. Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain. Int J Clin Pract 2008; 62: 1159–116
- Huskamp H A, Newhouse J P, Norcince J, Keating N L. Variation in patients' hospice costs. Inquiry 2008; 45: 232–244